Back to discover
Drug

Bilirubin

Research stage
Emerging research

Also known as bilirubin preparation.

RxNorm2285328ChEMBLCHEMBL501680UNIIRFM9X3LJ49
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Bilirubin
Aliases & brands
bilirubin preparation
RxNorm CUI
2285328
ChEMBL ID
CHEMBL501680
UNII
RFM9X3LJ49

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes6
Biological Products1Chemical and Drug Induced Liver Injury1Genetic Therapy1Muscular Atrophy, Spinal1Recombinant Fusion Proteins1Registries1
Journals, researchers & institutions
Top journals
  • Journal of hepatology1
Leading researchers
  • Chand D1
  • Kaufmann P1
  • Kleyn A1
  • Kullak-Ublick G1
  • McMillan H1
  • Mohr F1
  • Montgomery K1
  • Sun R1
Leading institutions
free-text, unnormalised
  • Children's Hospital of Eastern Ontario1
  • Switzerland; Department of Clinical Pharmacology and Toxicology1
  • Washington University School of Medicine1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Onasemnogene abeparvovec

Studied across 2 of the same disease areas as Bilirubin in the shared literature.

2 shared diseases1 shared paper
Prednisolone

Studied across 2 of the same disease areas as Bilirubin in the shared literature.

2 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature